GLAXOSMITHKLINE PLC

10% owner at QUEST DIAGNOSTICS INC · on record since Jun 9, 2006
10% owner at MEMORY PHARMACEUTICALS CORP · on record since Apr 6, 2004
10% owner at EPIX Pharmaceuticals, Inc. · on record since Dec 21, 2006
Former 10% owner at MEMORY PHARMACEUTICALS CORP · on record since Apr 12, 2004
10% owner at Redpoint Bio CORP · on record since Mar 22, 2007
10% owner at Innoviva, Inc. · on record since Feb 11, 2008
Director at QUEST DIAGNOSTICS INC · on record since Mar 19, 2009
10% owner at MAXYGEN INC · on record since Jan 4, 2010
10% owner at YALE SECURITIES LTD · on record since May 24, 2021
10% owner at Anacor Pharmaceuticals, Inc. · on record since Nov 24, 2010
10% owner at AMICUS THERAPEUTICS, INC. · on record since Nov 16, 2010
10% owner at Lyell Immunopharma, Inc. · on record since Jun 23, 2021
10% owner at ChemoCentryx, Inc. · on record since Feb 15, 2012
10% owner at RESPONSE GENETICS INC · on record since Sep 21, 2012
Director at HUMAN GENOME SCIENCES INC · on record since Aug 3, 2012
10% owner at HUMAN GENOME SCIENCES INC · on record since Aug 3, 2012
10% owner at CRISPR Therapeutics AG · on record since Oct 26, 2016
10% owner at OncoMed Pharmaceuticals Inc · on record since Jul 23, 2013
10% owner at · on record since Mar 26, 2014
Former 10% Shareholder at · on record since Feb 24, 2014
Former 10% Owner at · on record since Feb 20, 2014
10% owner at · on record since Feb 14, 2014
10% owner at · on record since Feb 12, 2014
Former 10% Shareholder at · on record since Feb 12, 2014
10% owner at · on record since Feb 5, 2014
10% owner at · on record since May 15, 2014
Former 10% Owner (1) at · on record since Oct 28, 2014
Former 10% Owner at · on record since Feb 24, 2015
10% owner at · on record since May 13, 2015
Former 10% Owner at · on record since Mar 30, 2017
10% owner at · on record since Jun 28, 2017
10% owner at · on record since Nov 7, 2017
10% owner at · on record since Jul 25, 2018
10% owner at · on record since Sep 20, 2018
10% owner at · on record since Jul 18, 2018
Former 10% holder at · on record since Aug 1, 2018
Former 10% holder at · on record since Oct 18, 2018
Director at · on record since May 30, 2019
10% owner at · on record since May 30, 2019
Director at · on record since Jun 26, 2019
10% owner at · on record since Jun 26, 2019
Director at · on record since Apr 24, 2019
10% owner at · on record since Apr 24, 2019
10% owner at · on record since Jul 24, 2019
10% owner at · on record since Oct 31, 2019
Former 10% Owner at · on record since Oct 22, 2019
Director at · on record since Jan 2, 2020
10% owner at · on record since Jan 2, 2020
Director at · on record since Jul 22, 2020
10% owner at · on record since Jul 22, 2020
Director at · on record since Jul 16, 2020
10% owner at · on record since Jul 16, 2020
Director at · on record since Feb 19, 2021
10% owner at · on record since Feb 11, 2021
Former 10% Owner at · on record since Sep 20, 2022
10% owner at · on record since Nov 4, 2022
10% owner at · on record since Jan 30, 2023
10% owner at · on record since May 3, 2005
10% owner at · on record since Jul 6, 2021
10% owner at · on record since Jun 27, 2018

Insider trading activity of GLAXOSMITHKLINE PLC

Transactions on record: 247; since Feb 13, 2004

Open-market buys: 57; $396.3T

Open-market sells: 26; $3B

Companies traded: 35; last filing Dec 15, 2025

Figures computed from official regulatory filings — .

Companies where GLAXOSMITHKLINE PLC has traded

3 tx · $66.8M · Dec 15, 2025
7 tx · $30T · Sep 20, 2022
13 tx · $5M · Jul 6, 2021
2 tx · Jun 23, 2021
1 tx · $392.1M · May 24, 2021
7 tx · $2.7M · Feb 19, 2021
8 tx · $5.5M · Sep 18, 2020
10 tx · $11.2M · Jul 30, 2020
6 tx · $6.5M · Jul 22, 2020
8 tx · $15M · Jul 16, 2020
8 tx · $18.8M · May 26, 2020
3 tx · $103M · May 21, 2020
14 tx · $14.6M · Oct 22, 2019
2 tx · Jul 24, 2019

Track record of GLAXOSMITHKLINE PLC

Statistical track record

Free account

Open-market buys: 59

Last buy: Dec 11, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of GLAXOSMITHKLINE PLC

Co-insiders of GLAXOSMITHKLINE PLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Wave Life Sciences, Inc.Listing on record	Dec 15, 2025	Buy	1,470,000	19.00 USD	$27.9M	conv 55Unusual sizeFirst in 12mo	SEC
Wave Life Sciences, Inc.Listing on record	Oct 1, 2024	Buy	2,791,930	8.00 USD	$22.3M	conv 29	SEC
Wave Life Sciences, Inc.Listing on record	Jan 30, 2024	Buy	3,300,000	5.00 USD	$16.5M	conv 38First in 12mo	SEC
Theravance Biopharma, Inc.Listing on record	Sep 20, 2022	OtherD (derivative)	0	—	n/a (No price was disclosed in the filing)		SEC
Theravance Biopharma, Inc.Listing on record	Sep 20, 2022	Other	-9,644,807	9.75 USD	$94M		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-589,939	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	8,380	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	27,345	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	635,646	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-513,312	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	12,979	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-1,081,434	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-10,055,408	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Buy	275,000	18.00 USD	$5M	conv 36Cluster	SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	14,917	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	1,505	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-59,527	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-331,399	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lyell Immunopharma, Inc.Listing on record	Jun 23, 2021	Other	30,253,189	—	n/a (No price was disclosed in the filing)		SEC
Lyell Immunopharma, Inc.Listing on record	Jun 23, 2021	OtherD (derivative)	-30,253,189	—	n/a (No price was disclosed in the filing)		SEC
YALE SECURITIES LTDListing unverified	May 24, 2021	Sell	-32,005,260	12.25 USD	$392.1M		SEC
Decibel Therapeutics, Inc.Listing unverified	Feb 19, 2021	Other	247,324	—	n/a (No price was disclosed in the filing)		SEC
Decibel Therapeutics, Inc.Listing unverified	Feb 19, 2021	Other	327,852	—	n/a (No price was disclosed in the filing)		SEC
Decibel Therapeutics, Inc.Listing unverified	Feb 19, 2021	OtherD (derivative)	-3,125,000	—	n/a (No price was disclosed in the filing)		SEC
Decibel Therapeutics, Inc.Listing unverified	Feb 19, 2021	OtherD (derivative)	-1,737,619	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Wave Life Sciences, Inc.Listing on record	Dec 15, 2025	Buy	1,470,000	19.00 USD	$27.9M	conv 55Unusual sizeFirst in 12mo	SEC
Wave Life Sciences, Inc.Listing on record	Oct 1, 2024	Buy	2,791,930	8.00 USD	$22.3M	conv 29	SEC
Wave Life Sciences, Inc.Listing on record	Jan 30, 2024	Buy	3,300,000	5.00 USD	$16.5M	conv 38First in 12mo	SEC
Theravance Biopharma, Inc.Listing on record	Sep 20, 2022	OtherD (derivative)	0	—	n/a (No price was disclosed in the filing)		SEC
Theravance Biopharma, Inc.Listing on record	Sep 20, 2022	Other	-9,644,807	9.75 USD	$94M		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-589,939	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	8,380	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	27,345	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	635,646	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-513,312	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	12,979	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-1,081,434	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-10,055,408	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Buy	275,000	18.00 USD	$5M	conv 36Cluster	SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	14,917	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	Other	1,505	—	n/a (No price was disclosed in the filing)		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-59,527	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CVRx, Inc.Listing on record	Jul 6, 2021	OtherD (derivative)	-331,399	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lyell Immunopharma, Inc.Listing on record	Jun 23, 2021	Other	30,253,189	—	n/a (No price was disclosed in the filing)		SEC
Lyell Immunopharma, Inc.Listing on record	Jun 23, 2021	OtherD (derivative)	-30,253,189	—	n/a (No price was disclosed in the filing)		SEC
YALE SECURITIES LTDListing unverified	May 24, 2021	Sell	-32,005,260	12.25 USD	$392.1M		SEC
Decibel Therapeutics, Inc.Listing unverified	Feb 19, 2021	Other	247,324	—	n/a (No price was disclosed in the filing)		SEC
Decibel Therapeutics, Inc.Listing unverified	Feb 19, 2021	Other	327,852	—	n/a (No price was disclosed in the filing)		SEC
Decibel Therapeutics, Inc.Listing unverified	Feb 19, 2021	OtherD (derivative)	-3,125,000	—	n/a (No price was disclosed in the filing)		SEC
Decibel Therapeutics, Inc.Listing unverified	Feb 19, 2021	OtherD (derivative)	-1,737,619	—	n/a (No price was disclosed in the filing)		SEC